Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty Corporation in July 2024. XOMA Royalty Corporation was incorporated in 1981 and is headquartered in Emeryville, California. more
Time Frame | XOMAP | Sector | S&P500 |
---|---|---|---|
1-Week Return | -0.04% | -3.72% | -0.05% |
1-Month Return | -0.08% | -1.85% | 2.75% |
3-Month Return | 0.98% | -11.4% | 7.4% |
6-Month Return | 1.71% | -4.41% | 10.47% |
1-Year Return | -0.5% | 4.13% | 27.57% |
3-Year Return | -2.64% | 0.3% | 29.56% |
5-Year Return | 5.9% | 36.62% | 89.3% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 18.37M | 29.39M | 38.16M | 6.03M | 4.76M | [{"date":"2019-12-31","value":48.14,"profit":true},{"date":"2020-12-31","value":77,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.79,"profit":true},{"date":"2023-12-31","value":12.47,"profit":true}] |
Cost of Revenue | 1.25M | 170.00K | 171.00K | 97.00K | 897.00K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":13.57,"profit":true},{"date":"2021-12-31","value":13.65,"profit":true},{"date":"2022-12-31","value":7.74,"profit":true},{"date":"2023-12-31","value":71.59,"profit":true}] |
Gross Profit | 17.12M | 29.21M | 37.99M | 5.93M | 3.86M | [{"date":"2019-12-31","value":45.06,"profit":true},{"date":"2020-12-31","value":76.9,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":15.61,"profit":true},{"date":"2023-12-31","value":10.16,"profit":true}] |
Gross Margin | 93.18% | 99.42% | 99.55% | 98.39% | 81.15% | [{"date":"2019-12-31","value":93.6,"profit":true},{"date":"2020-12-31","value":99.87,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":98.83,"profit":true},{"date":"2023-12-31","value":81.51,"profit":true}] |
Operating Expenses | 22.25M | 16.97M | 20.63M | 23.44M | 45.71M | [{"date":"2019-12-31","value":48.69,"profit":true},{"date":"2020-12-31","value":37.12,"profit":true},{"date":"2021-12-31","value":45.14,"profit":true},{"date":"2022-12-31","value":51.28,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | (3.88M) | 12.42M | 17.53M | (17.41M) | (41.85M) | [{"date":"2019-12-31","value":-22.16,"profit":false},{"date":"2020-12-31","value":70.83,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-99.34,"profit":false},{"date":"2023-12-31","value":-238.74,"profit":false}] |
Total Non-Operating Income/Expense | (16.00K) | (2.46M) | (2.10M) | 295.00K | 448.00K | [{"date":"2019-12-31","value":-3.57,"profit":false},{"date":"2020-12-31","value":-549.78,"profit":false},{"date":"2021-12-31","value":-468.97,"profit":false},{"date":"2022-12-31","value":65.85,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Pre-Tax Income | (1.98M) | 11.80M | 15.89M | (17.12M) | (40.83M) | [{"date":"2019-12-31","value":-12.47,"profit":false},{"date":"2020-12-31","value":74.25,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-107.74,"profit":false},{"date":"2023-12-31","value":-256.98,"profit":false}] |
Income Taxes | 5.72M | (1.50M) | 91.00K | (15.00K) | 732.11K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-26.26,"profit":false},{"date":"2021-12-31","value":1.59,"profit":true},{"date":"2022-12-31","value":-0.26,"profit":false},{"date":"2023-12-31","value":12.81,"profit":true}] |
Income After Taxes | (7.70M) | 13.30M | 15.80M | (17.10M) | (41.56M) | [{"date":"2019-12-31","value":-48.73,"profit":false},{"date":"2020-12-31","value":84.18,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-108.27,"profit":false},{"date":"2023-12-31","value":-263.09,"profit":false}] |
Income From Continuous Operations | (1.98M) | 13.30M | 15.80M | (17.10M) | (26.70M) | [{"date":"2019-12-31","value":-12.55,"profit":false},{"date":"2020-12-31","value":84.18,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-108.27,"profit":false},{"date":"2023-12-31","value":-169,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (7.70M) | 13.30M | 15.80M | (17.10M) | (40.83M) | [{"date":"2019-12-31","value":-48.73,"profit":false},{"date":"2020-12-31","value":84.18,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-108.27,"profit":false},{"date":"2023-12-31","value":-258.46,"profit":false}] |
EPS (Diluted) | (1.14) | 0.36 | 0.17 | (1.97) | - | [{"date":"2019-12-31","value":-316.39,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":47.22,"profit":true},{"date":"2022-12-31","value":-547.22,"profit":false},{"date":"2023-12-31","value":"-","profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
XOMAP | |
---|---|
Cash Ratio | 6.76 |
Current Ratio | 7.52 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
XOMAP | |
---|---|
ROA (LTM) | -5.54% |
ROE (LTM) | -31.41% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
XOMAP | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.62 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.38 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
XOMAP | |
---|---|
Trailing PE | 25.43 |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
XOMA Corp (XOMAP) share price today is $25.8499
Yes, Indians can buy shares of XOMA Corp (XOMAP) on Vested. To buy XOMA Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in XOMAP stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of XOMA Corp (XOMAP) via the Vested app. You can start investing in XOMA Corp (XOMAP) with a minimum investment of $1.
You can invest in shares of XOMA Corp (XOMAP) via Vested in three simple steps:
The 52-week high price of XOMA Corp (XOMAP) is $26.51. The 52-week low price of XOMA Corp (XOMAP) is $22.8.
The price-to-earnings (P/E) ratio of XOMA Corp (XOMAP) is 25.4347
The price-to-book (P/B) ratio of XOMA Corp (XOMAP) is 0.00
The dividend yield of XOMA Corp (XOMAP) is 8.47%
The market capitalization of XOMA Corp (XOMAP) is
The stock symbol (or ticker) of XOMA Corp is XOMAP